02:23

Moderna Covid-19 vaccine nearly 95 per cent effective in second promising trial for US drug makers

Moderna says its Covid-19 vaccine is 94.5 per cent effective based on clinical trials

  • Together with Pfizer’s vaccine, the United States could have two vaccines authorised for emergency use in December
  • A key advantage of Moderna’s vaccine is that it does not need ultra-cold storage like Pfizer’s, making it easier to distribute

Topic |   Coronavirus pandemic

02:23

Moderna Covid-19 vaccine nearly 95 per cent effective in second promising trial for US drug makers

READ FULL ARTICLE